Elon Musk’s Neuralink says it has US FDA approval for human trials

Neuralink, Elon Musk’s brain-implant company, said it received approval from the US Food and Drug Administration to conduct human clinical trials.

“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” the company said Thursday in a tweet.

The FDA and Neuralink did not immediately respond to a request for comment. The startup is developing a small device that will link the brain to a computer, consisting of electrode-laced wires. Placing the device requires drilling into the skull.